Journal Title
ONCOGENE

ONCOGENE

ISSN / eISSN
0950-9232 / 1476-5594
Aims and Scope
Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and builds on previous studies, in particular those that lead to establishing new paradigms in the etio-pathogenesis, diagnosis, treatment, or prevention of cancers, and in processes that drive metastatic spread, and provide important insights into cancer biology beyond what has been revealed thus far.
Subject Area

BIOCHEMISTRY & MOLECULAR BIOLOGY

GENETICS & HEREDITY

CELL BIOLOGY

CiteScore
15.30 View Trend
CiteScore Ranking
Category Quartile Rank
Biochemistry, Genetics and Molecular Biology - Genetics Q1 #18/347
Biochemistry, Genetics and Molecular Biology - Molecular Biology Q1 #35/410
Biochemistry, Genetics and Molecular Biology - Cancer Research Q1 #25/230
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY Q1
CELL BIOLOGY Q1
GENETICS & HEREDITY Q1
ONCOLOGY Q1
H-index
312
Country/Area of Publication
ENGLAND
Publisher
Springer Nature
Publication Frequency
Weekly
Year Publication Started
1997
Annual Article Volume
266
Open Access
NO
Contact
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Originally, this journal was still acceptable, but in recent years, there has been a serious issue of watered-down content. Although the impact factor is around 7-8, the actual quality is only about 5. If you want to increase your impact factor, get promoted, or find a job, you can submit to this journal. It's easy to get accepted, and the cost-effectiveness is high.

However, if you are serious about doing research, be cautious about submitting to this journal. In the future, experts may look down upon it, and when applying for grants, the impression of experts towards this journal is not good. Based on the level of articles in the past two years, it is also possible that it will be included in the warning list. Don't submit your good articles to this journal. First, try Cancer Research, Cell Reports, or reputable domestic journals like Protein Cell.
2021-05-05

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now